Introduction
Characterization of ambulatory blood pressure (ABP) is superior to measurement of casual BP in the assessment of cardiovascular risk in adults. The technique has gained popularity for use in children and adolescents as it provides a more representative sample of the individual BP profile. Validation of devices that accurately measure ABP in children is particularly challenging. We have conducted studies in children and adolescents using the AM5600 ABP monitor [1] , which employs an auscultatory method of measurement as the primary measurement technique, but also has an oscillometric method of measurement as the alternative mode. In this study, we report the validation of the monitor for measurement of ABP in children and adolescents using both the British Hypertension Society (BHS) and the American Association for the Advancement of Medical Instrumentation (AAMI) criteria for validation of test device accuracy. The BHS grades devices based upon the absolute difference between the simultaneously obtained values made with the device as compared with the mercury standard. Grades are given according to the cumulative percentage of readings within 5, 10, and 15 mmHg. [2] The AAMI standard requires that the mean BP of the test device does not differ more than 5 mmHg from the mercury standard, and that the standard deviation of that difference not be more than 8 mmHg. We used both criteria to assess the accuracy of the measurement made in 111 participants.
Methods
Participants were recruited from primary care clinics and from children referred to University of Tennessee Medical Group nephrology or cardiology clinics for evaluation of elevated blood pressure. Children of 6-18 years of age with a casual BP greater than or equal to 90th percentile or a first-degree relative on antihypertensive therapy were eligible for the study. A small group of healthy normal children were also enrolled. Informed consent was obtained from the parent and assent obtained from the study participant if the participant was a minor. The research protocol was approved by the University of Tennessee Health Science Center Institutional Review Board and followed the guidelines for good clinical practice.
Study procedures
Participant's height and weight were measured using a balance beam scale and pediatric wall-mounted stadiometer. Height percentile was calculated using the CDC NHANES III data tables by age in months [3] . Body mass index was calculated and assigned a percentile using the CDC tables from NHANES III [3] . Ethnicity was categorized as reported by the participant.
ABP monitoring was performed using the AM5600 ABP monitor (Advanced Biosensor, Columbia, South Carolina, USA). Information regarding the use of this device in adults has been previously published [4] . The monitors use an auscultatory technique to detect systolic BP (SBP) at Korotkoff phase I and diastolic BP (DBP) at Korotkoff phase V. After selection of the appropriate cuff size, the brachial artery of the nondominant arm at the anticubital fossa was located. A microphone was taped to the participant's arm over the strongest impulse followed by placement of the cuff and electrodes. During the AM5600 'office check period', with the participant in a seated position, a minimum of three readings were taken simultaneously in the same arm via a three-way stopcock, with a mercury sphygmomanometer and the AM5600, using the recorder's BP cuff. Values for SBP and DBP were obtained in the same arm for a total of three each for the mercury manometer and the ambulatory blood pressure measurement (ABPM) device. Two trained research coordinators performed all measurements according to the American Heart Association protocol for the measurement of BP [5] . Each manual reading was recorded before recording of the ABPM device reading.
Statistical analysis
SAS software (SAS Institute Inc., Cary, North Carolina, USA) was used for statistical analyses to calculate the mean, standard deviation, distribution, and normal plots of variables studied. Intermethod reliability between the baseline readings obtained using the mercury sphygmomanometer and the AM5600 ABPM system was assessed using analysis of variance, mixed effects model. Three calibration readings taken simultaneously by each method were averaged for calculation of the mean difference between each method and the mean of the two methods for Bland-Altman analysis. The mean of the differences and standard deviation of the mean differences and 95% confidence intervals were also calculated for SBP and DBP. The cumulative percentage of AM5600 readings that differed from the mercury readings by less than or equal to 5, 10, and 15 mmHg was also calculated for both SBP and DBP.
Results
The characteristics of the participants are found in Table 1 . A predominance of African-American children as well as males was observed. No significant differences between the measurement by the AM5600 and the mercury manometer for either SBP or DBP were observed. The Pearson's correlation coefficients were 0.992 and 0.979 for SBP and DBP, respectively, with coefficients of variation of 1.5 and 3.5%. No statistical differences between the two methods for SBP or DBP were observed. BP data are summarized in Table 2 .
The mean of the difference between the AM5600 and the mercury manometer was 0.29 ± 3.5 and 0.15 ± 2.8 mmHg for SBP and DBP, respectively, thus fulfilling the AAMI criteria. The cumulative percentage of readings between the two devices, which differed by less than or equal to 5, 10, and 15 mmHg was within the grade of A according to the BSH ( Table 2 ).
Data are represented as Bland-Altman plots, which show the mean of each participant's BP as measured by the AM5600 and the mercury manometer plotted against the difference of the two readings as well as the percentage difference between the two techniques ( Fig. 1 ).
Discussion
We assessed the accuracy of the AM5600 device as compared with the best available standard, the mercury manometer. Baseline readings during the calibration period were not statistically different. Using the BHS grading criteria, the device received a grade of A for both SBP and DBP. Using the AAMI standards, the device fulfilled the criteria for validation. Therefore, we conclude that this device is accurate for the measurement of ABP in children and adolescents. The disadvantage of the auscultatory technique includes a greater percentage of missed readings because of the potential for movement error. This study did not compare the auscultatory Values are mean ± standard deviation, range given in parentheses. BP, blood pressure.
technique with the oscillometric technique, rather the accuracy of the AM5600 device was compared with mercury. The overall performance of this device has been described previously [4] . This device was used for our studies employing ABPM because of the experience of the investigators (P.A.R. and B.S.A.) with the device and the ready availability of the device for use in the pilot study. Very few studies have reported validation of an ambulatory device in children; this problem is discussed in two recent reviews on ABP monitoring in children [6, 7] . Belsha et al. [8] reported that the Spacelabs 90207 device (Issaquah, Washington, USA) achieved a grade of C for systolic and a grade of D for DBP, and therefore, it was not recommended. Although the Spacelabs 20217 device is the most commonly used device in children based upon published studies, and the device has been recommended for use in adults; it has not been validated in children. The QuietTrak device, which is an auscultatory monitor, was validated and recommended for use in children, but is no longer manufactured [9] . The oscillometric device, TM-2421, achieved a grade of A for systolic and B for diastolic but has a questionable recommendation [10] but this device is also no longer available.
We conclude that the AM5600 fulfills both the AAMI and the BHS criteria for validation of ABPM devices in children and adolescents over a wide range of sizes. 
